Barbara Segura

Aug 15, 2024 | nature.com | Anna Inguanzo |Rosaleena Mohanty |Konstantinos Poulakis |Daniel R. Ferreira |Barbara Segura |Franziska Albrecht | +3 more

AbstractParkinson’s disease (PD) is clinically heterogeneous, which suggests the existence of subtypes; however, there has been no consensus regarding their characteristics. This study included 633 PD individuals across distinct cohorts: unmedicated de novo PD, medicated PD, mild-moderate PD, and a cohort based on diagnostic work-up in clinical practice. Additionally, 233 controls were included.

Apr 12, 2024 | nature.com | Christopher Schwarz |Eric C Westman |Barbara Segura |Bradley F. Boeve |Dag Aarsland |Annegret Habich

AbstractSex differences permeate many aspects of dementia with Lewy bodies (DLB), yet sex differences in patterns of neurodegeneration in DLB remain largely unexplored. Here, we test whether grey matter networks differ between sexes in DLB and compare these findings to sex differences in healthy controls. In this cross-sectional study, we analysed clinical and neuroimaging data of patients with DLB and cognitively healthy controls matched for age and sex.

Mar 22, 2024 | nature.com | Javier Oltra |Barbara Segura |Thilo van Eimeren |Naroa Ibarretxe-Bilbao |María Díez-Cirarda |Olaia Lucas-Jiménez | +4 more

AbstractClinical, cognitive, and atrophy characteristics depending on sex have been previously reported in Parkinson’s disease (PD). However, though sex differences in cortical gray matter measures in early drug naïve patients have been described, little is known about differences in cortical thickness (CTh) as the disease advances.

Dec 21, 2023 | onlinelibrary.wiley.com | Neus Balaguer Cano |Barbara Segura |Javier Payo Bejar |Mar Ariza

Introduction Post-coronavirus disease 2019 (COVID-19) condition (PCC) is defined as the continuance or onset of new symptoms 3 months after the initial SARS-CoV-2 infection, which last at least 2 months and cannot be attributed to another cause.1 The prevalence of PCC is unknown, as it varies according to study cohorts, methodology, SARS-CoV-2 variants, and vaccination status, but it is estimated that one in eight people with COVID-19 will develop PCC.2, 3 Fatigue, dyspnea, and altered smell...

Jun 2, 2023 | dialnet.unirioja.es | Barbara Segura |Cristina Rojo |Eduardo Ramos Velasco |Yolanda Carrascal Hinojal

Yolanda Carrascal[1];Bárbara Segura[2];Cristina Sánchez[2];Eduardo Velasco[2][1]Servicio de Cirugía Cardiaca, Hospital Clínico Universitario de Valladolid, Valladolid, España; Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, Universidad de Valladolid, Valladolid, España[2]Servicio de Cirugía Cardiaca, Hospital Clínico Universitario de Valladolid, Valladolid, EspañaLocalización: Revista española de cardiología, ISSN 0300-8932, Vol. 76, Nº. 6, 2023, págs.